Physician profile
John P Sullivan
NPI 1942294095
$15,116.33
in general payments reported to CMS, 2019-2025
35 companies · $2,363 in 2025
The $2,363 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,099 · 2020: $608 · 2021: $3,886 · 2022: $2,856 · 2023: $618 · 2024: $1,687 · 2025: $2,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,637 · Travel and Lodging: $1,965 · Education: $67.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,636.50 |
| Travel and Lodging | $1,964.52 |
| Education | $67.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,226.62 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $2,625.32 | 2019-2025 | Oxford, Affixus, Zmr |
| Smith+Nephew, INC. | $1,598.72 | 2019-2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Renasys Go V2 Home, Pico |
| Prodigy Surgical Distribution, INC. | $1,463.92 | 2021-2024 | |
| Pacira Pharmaceuticals Incorporated | $694.52 | 2022-2025 | Iovera, Exparel |
| Southern Edge Orthopaedics, INC. | $611.55 | 2024-2025 | |
| Depuy Synthes Sales INC. | $468.25 | 2019-2024 | Na, Monovisc, Orthovisc |
| Amgen INC. | $353.33 | 2019-2023 | Evenity, Prolia |
| Pacira Therapeutics, INC. | $301.35 | 2019-2021 | |
| Stryker Corporation | $264.46 | 2019-2025 | Mako, Aequalis Perform |
| Sanofi-Aventis U.S. LLC | $207.84 | 2019-2023 | |
| Lima USA, INC. | $156.22 | 2022-2023 | Smr Shoulder |
| Horizon Therapeutics Plc | $142.54 | 2020-2021 | |
| Fidia Pharma USA INC. | $138.00 | 2019-2022 | |
| Next Science LLC | $132.07 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $119.04 | 2023 | Aquabeam Robotic System |
| Medtronic, INC. | $63.90 | 2021-2022 | |
| Nevro Corp. | $58.22 | 2021-2022 | |
| Medacta USA, INC. | $58.07 | 2022-2023 | Primary Shoulder |
| Bioventus LLC | $56.92 | 2019-2022 | |
| Djo, LLC | $56.16 | 2021 | |
| Heron Therapeutics, INC. | $41.55 | 2021-2022 | |
| Heraeus Medical, LLC. | $32.66 | 2019-2022 | |
| Stimwave Technologies Incorporated | $28.36 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $26.01 | 2025 | |
| Vericel Corporation | $24.92 | 2022 | |
| Moximed, INC | $22.98 | 2025 | Misha Knee System, Small, Left |
| Ferring Pharmaceuticals INC. | $22.18 | 2020 | |
| Medtronic USA, INC. | $20.90 | 2020 | |
| Highridge Medical LLC | $20.61 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Masimo Corporation | $19.68 | 2021 | |
| Baxter Healthcare | $16.51 | 2021 | |
| Ibsa Pharma INC. | $16.42 | 2023 | Tirosint, Licart |
| Radius Health, INC. | $14.63 | 2019 | |
| Molnlycke Health Care US, LLC | $11.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.